Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study

ABSTRACT Sex steroids are important determinants of bone acquisition and bone homeostasis. Cross‐sex hormonal treatment (CHT) in transgender persons can affect bone mineral density (BMD). The aim of this study was to investigate in a prospective observational multicenter study the first‐year effects...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of bone and mineral research 2017-06, Vol.32 (6), p.1252-1260
Hauptverfasser: Wiepjes, Chantal M, Vlot, Mariska C, Klaver, Maartje, Nota, Nienke M, de Blok, Christel JM, de Jongh, Renate T, Lips, Paul, Heijboer, Annemieke C, Fisher, Alessandra D, Schreiner, Thomas, T'Sjoen, Guy, den Heijer, Martin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1260
container_issue 6
container_start_page 1252
container_title Journal of bone and mineral research
container_volume 32
creator Wiepjes, Chantal M
Vlot, Mariska C
Klaver, Maartje
Nota, Nienke M
de Blok, Christel JM
de Jongh, Renate T
Lips, Paul
Heijboer, Annemieke C
Fisher, Alessandra D
Schreiner, Thomas
T'Sjoen, Guy
den Heijer, Martin
description ABSTRACT Sex steroids are important determinants of bone acquisition and bone homeostasis. Cross‐sex hormonal treatment (CHT) in transgender persons can affect bone mineral density (BMD). The aim of this study was to investigate in a prospective observational multicenter study the first‐year effects of CHT on BMD in transgender persons. A total of 231 transwomen and 199 transmen were included who completed the first year of CHT. Transwomen were treated with cyproterone acetate and oral or transdermal estradiol; transmen received transdermal or intramuscular testosterone. A dual‐energy X‐ray absorptiometry (DXA) was performed to measure lumbar spine (LS), total hip (TH), and femoral neck (FN) BMD before and after 1 year of CHT. In transwomen, an increase in LS (+3.67%, 95% confidence interval [CI] 3.20 to 4.13%, p 
doi_str_mv 10.1002/jbmr.3102
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1884168020</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1907558516</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3882-1cc2320913c7a8a3c3d12d2cbd169ba3490b0bb185310df9da8ef2792d54714e3</originalsourceid><addsrcrecordid>eNp1kU9P3DAQxa2qVVloD3wBZKmXcgiM7fxxelsoFCpWoHZ74BQ5zkTyKrG3tkO1R745XhZ6qNTTaKTfe5p5j5BDBicMgJ-u2tGfCAb8DZmxgossLyV7S2YgZZ5BLtge2Q9hBQBlUZbvyR6XogKR8xl5PHMW6cJY9GqgX9EGEzf02mqPKmCgxtKlVzbQO_TBpTnvI3rK6D0qT11Pr5wfnU3aZVLEEW38Qud0MQ3R6LQk9s67sEYdzQPS2zagf1DRPEt-xqnbfCDvejUE_PgyD8ivy4vl-VV2c_vt-nx-k2khJc-Y1lxwqJnQlZJKaNEx3nHddqysWyXyGlpoWyaLFETX152S2POq5l2RVyxHcUA-73zX3v2eMMRmNEHjMCiLbgoNS2GxUgKHhH76B125yaeLE1VDVRSyYGWijneUTg8Gj32z9mZUftMwaLa9NNtemm0viT16cZzaEbu_5GsRCTjdAX_MgJv_OzXfzxY_ni2fAJPFl3c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1907558516</pqid></control><display><type>article</type><title>Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Wiepjes, Chantal M ; Vlot, Mariska C ; Klaver, Maartje ; Nota, Nienke M ; de Blok, Christel JM ; de Jongh, Renate T ; Lips, Paul ; Heijboer, Annemieke C ; Fisher, Alessandra D ; Schreiner, Thomas ; T'Sjoen, Guy ; den Heijer, Martin</creator><creatorcontrib>Wiepjes, Chantal M ; Vlot, Mariska C ; Klaver, Maartje ; Nota, Nienke M ; de Blok, Christel JM ; de Jongh, Renate T ; Lips, Paul ; Heijboer, Annemieke C ; Fisher, Alessandra D ; Schreiner, Thomas ; T'Sjoen, Guy ; den Heijer, Martin</creatorcontrib><description>ABSTRACT Sex steroids are important determinants of bone acquisition and bone homeostasis. Cross‐sex hormonal treatment (CHT) in transgender persons can affect bone mineral density (BMD). The aim of this study was to investigate in a prospective observational multicenter study the first‐year effects of CHT on BMD in transgender persons. A total of 231 transwomen and 199 transmen were included who completed the first year of CHT. Transwomen were treated with cyproterone acetate and oral or transdermal estradiol; transmen received transdermal or intramuscular testosterone. A dual‐energy X‐ray absorptiometry (DXA) was performed to measure lumbar spine (LS), total hip (TH), and femoral neck (FN) BMD before and after 1 year of CHT. In transwomen, an increase in LS (+3.67%, 95% confidence interval [CI] 3.20 to 4.13%, p &lt; 0.001), TH (+0.97%, 95% CI 0.62 to 1.31%, p &lt; 0.001), and FN (+1.86%, 95% CI 1.41 to 2.31%, p &lt; 0.001) BMD was found. In transmen, TH BMD increased after 1 year of CHT (+1.04%, 95% CI 0.64 to 1.44%, p &lt; 0.001). No changes were observed in FN BMD (–0.46%, 95% CI –1.07 to 0.16%, p = 0.144). The increase in LS BMD was larger in transmen aged ≥50 years (+4.32%, 95% CI 2.28 to 6.36%, p = 0.001) compared with transmen aged &lt;50 years (+0.68%, 95% CI 0.19 to 1.17%, p = 0.007). In conclusion, BMD increased in transgender persons after 1 year of CHT. In transmen of postmenopausal age, the LS BMD increased more than in younger transmen, which may lead to the hypothesis that the increase in BMD in transmen is the result of the aromatization of testosterone to estradiol. © 2017 American Society for Bone and Mineral Research.</description><identifier>ISSN: 0884-0431</identifier><identifier>EISSN: 1523-4681</identifier><identifier>DOI: 10.1002/jbmr.3102</identifier><identifier>PMID: 28370342</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>17β-Estradiol ; Adult ; Age ; Age Factors ; Alcohol Drinking - adverse effects ; Body Weight - drug effects ; Bone density ; Bone Density - drug effects ; Bone Density - physiology ; Bone mineral density ; Bone turnover ; Cigarette Smoking - adverse effects ; CROSS‐SEX HORMONAL TREATMENT ; Cyproterone acetate ; Dual energy X-ray absorptiometry ; DXA ; Estradiol - pharmacology ; Female ; Femur ; Hip ; Homeostasis ; Humans ; Male ; Observational studies ; Oral cavity ; OSTEOPOROSIS ; Post-menopause ; Prospective Studies ; Sex ; SEX STEROIDS ; Spine (lumbar) ; Steroid hormones ; Testosterone ; Testosterone - pharmacology ; Transgender Persons ; Vitamin D - pharmacology ; Young Adult</subject><ispartof>Journal of bone and mineral research, 2017-06, Vol.32 (6), p.1252-1260</ispartof><rights>2017 American Society for Bone and Mineral Research</rights><rights>2017 American Society for Bone and Mineral Research.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3882-1cc2320913c7a8a3c3d12d2cbd169ba3490b0bb185310df9da8ef2792d54714e3</citedby><cites>FETCH-LOGICAL-c3882-1cc2320913c7a8a3c3d12d2cbd169ba3490b0bb185310df9da8ef2792d54714e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjbmr.3102$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjbmr.3102$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28370342$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wiepjes, Chantal M</creatorcontrib><creatorcontrib>Vlot, Mariska C</creatorcontrib><creatorcontrib>Klaver, Maartje</creatorcontrib><creatorcontrib>Nota, Nienke M</creatorcontrib><creatorcontrib>de Blok, Christel JM</creatorcontrib><creatorcontrib>de Jongh, Renate T</creatorcontrib><creatorcontrib>Lips, Paul</creatorcontrib><creatorcontrib>Heijboer, Annemieke C</creatorcontrib><creatorcontrib>Fisher, Alessandra D</creatorcontrib><creatorcontrib>Schreiner, Thomas</creatorcontrib><creatorcontrib>T'Sjoen, Guy</creatorcontrib><creatorcontrib>den Heijer, Martin</creatorcontrib><title>Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study</title><title>Journal of bone and mineral research</title><addtitle>J Bone Miner Res</addtitle><description>ABSTRACT Sex steroids are important determinants of bone acquisition and bone homeostasis. Cross‐sex hormonal treatment (CHT) in transgender persons can affect bone mineral density (BMD). The aim of this study was to investigate in a prospective observational multicenter study the first‐year effects of CHT on BMD in transgender persons. A total of 231 transwomen and 199 transmen were included who completed the first year of CHT. Transwomen were treated with cyproterone acetate and oral or transdermal estradiol; transmen received transdermal or intramuscular testosterone. A dual‐energy X‐ray absorptiometry (DXA) was performed to measure lumbar spine (LS), total hip (TH), and femoral neck (FN) BMD before and after 1 year of CHT. In transwomen, an increase in LS (+3.67%, 95% confidence interval [CI] 3.20 to 4.13%, p &lt; 0.001), TH (+0.97%, 95% CI 0.62 to 1.31%, p &lt; 0.001), and FN (+1.86%, 95% CI 1.41 to 2.31%, p &lt; 0.001) BMD was found. In transmen, TH BMD increased after 1 year of CHT (+1.04%, 95% CI 0.64 to 1.44%, p &lt; 0.001). No changes were observed in FN BMD (–0.46%, 95% CI –1.07 to 0.16%, p = 0.144). The increase in LS BMD was larger in transmen aged ≥50 years (+4.32%, 95% CI 2.28 to 6.36%, p = 0.001) compared with transmen aged &lt;50 years (+0.68%, 95% CI 0.19 to 1.17%, p = 0.007). In conclusion, BMD increased in transgender persons after 1 year of CHT. In transmen of postmenopausal age, the LS BMD increased more than in younger transmen, which may lead to the hypothesis that the increase in BMD in transmen is the result of the aromatization of testosterone to estradiol. © 2017 American Society for Bone and Mineral Research.</description><subject>17β-Estradiol</subject><subject>Adult</subject><subject>Age</subject><subject>Age Factors</subject><subject>Alcohol Drinking - adverse effects</subject><subject>Body Weight - drug effects</subject><subject>Bone density</subject><subject>Bone Density - drug effects</subject><subject>Bone Density - physiology</subject><subject>Bone mineral density</subject><subject>Bone turnover</subject><subject>Cigarette Smoking - adverse effects</subject><subject>CROSS‐SEX HORMONAL TREATMENT</subject><subject>Cyproterone acetate</subject><subject>Dual energy X-ray absorptiometry</subject><subject>DXA</subject><subject>Estradiol - pharmacology</subject><subject>Female</subject><subject>Femur</subject><subject>Hip</subject><subject>Homeostasis</subject><subject>Humans</subject><subject>Male</subject><subject>Observational studies</subject><subject>Oral cavity</subject><subject>OSTEOPOROSIS</subject><subject>Post-menopause</subject><subject>Prospective Studies</subject><subject>Sex</subject><subject>SEX STEROIDS</subject><subject>Spine (lumbar)</subject><subject>Steroid hormones</subject><subject>Testosterone</subject><subject>Testosterone - pharmacology</subject><subject>Transgender Persons</subject><subject>Vitamin D - pharmacology</subject><subject>Young Adult</subject><issn>0884-0431</issn><issn>1523-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU9P3DAQxa2qVVloD3wBZKmXcgiM7fxxelsoFCpWoHZ74BQ5zkTyKrG3tkO1R745XhZ6qNTTaKTfe5p5j5BDBicMgJ-u2tGfCAb8DZmxgossLyV7S2YgZZ5BLtge2Q9hBQBlUZbvyR6XogKR8xl5PHMW6cJY9GqgX9EGEzf02mqPKmCgxtKlVzbQO_TBpTnvI3rK6D0qT11Pr5wfnU3aZVLEEW38Qud0MQ3R6LQk9s67sEYdzQPS2zagf1DRPEt-xqnbfCDvejUE_PgyD8ivy4vl-VV2c_vt-nx-k2khJc-Y1lxwqJnQlZJKaNEx3nHddqysWyXyGlpoWyaLFETX152S2POq5l2RVyxHcUA-73zX3v2eMMRmNEHjMCiLbgoNS2GxUgKHhH76B125yaeLE1VDVRSyYGWijneUTg8Gj32z9mZUftMwaLa9NNtemm0viT16cZzaEbu_5GsRCTjdAX_MgJv_OzXfzxY_ni2fAJPFl3c</recordid><startdate>201706</startdate><enddate>201706</enddate><creator>Wiepjes, Chantal M</creator><creator>Vlot, Mariska C</creator><creator>Klaver, Maartje</creator><creator>Nota, Nienke M</creator><creator>de Blok, Christel JM</creator><creator>de Jongh, Renate T</creator><creator>Lips, Paul</creator><creator>Heijboer, Annemieke C</creator><creator>Fisher, Alessandra D</creator><creator>Schreiner, Thomas</creator><creator>T'Sjoen, Guy</creator><creator>den Heijer, Martin</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TS</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201706</creationdate><title>Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study</title><author>Wiepjes, Chantal M ; Vlot, Mariska C ; Klaver, Maartje ; Nota, Nienke M ; de Blok, Christel JM ; de Jongh, Renate T ; Lips, Paul ; Heijboer, Annemieke C ; Fisher, Alessandra D ; Schreiner, Thomas ; T'Sjoen, Guy ; den Heijer, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3882-1cc2320913c7a8a3c3d12d2cbd169ba3490b0bb185310df9da8ef2792d54714e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>17β-Estradiol</topic><topic>Adult</topic><topic>Age</topic><topic>Age Factors</topic><topic>Alcohol Drinking - adverse effects</topic><topic>Body Weight - drug effects</topic><topic>Bone density</topic><topic>Bone Density - drug effects</topic><topic>Bone Density - physiology</topic><topic>Bone mineral density</topic><topic>Bone turnover</topic><topic>Cigarette Smoking - adverse effects</topic><topic>CROSS‐SEX HORMONAL TREATMENT</topic><topic>Cyproterone acetate</topic><topic>Dual energy X-ray absorptiometry</topic><topic>DXA</topic><topic>Estradiol - pharmacology</topic><topic>Female</topic><topic>Femur</topic><topic>Hip</topic><topic>Homeostasis</topic><topic>Humans</topic><topic>Male</topic><topic>Observational studies</topic><topic>Oral cavity</topic><topic>OSTEOPOROSIS</topic><topic>Post-menopause</topic><topic>Prospective Studies</topic><topic>Sex</topic><topic>SEX STEROIDS</topic><topic>Spine (lumbar)</topic><topic>Steroid hormones</topic><topic>Testosterone</topic><topic>Testosterone - pharmacology</topic><topic>Transgender Persons</topic><topic>Vitamin D - pharmacology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wiepjes, Chantal M</creatorcontrib><creatorcontrib>Vlot, Mariska C</creatorcontrib><creatorcontrib>Klaver, Maartje</creatorcontrib><creatorcontrib>Nota, Nienke M</creatorcontrib><creatorcontrib>de Blok, Christel JM</creatorcontrib><creatorcontrib>de Jongh, Renate T</creatorcontrib><creatorcontrib>Lips, Paul</creatorcontrib><creatorcontrib>Heijboer, Annemieke C</creatorcontrib><creatorcontrib>Fisher, Alessandra D</creatorcontrib><creatorcontrib>Schreiner, Thomas</creatorcontrib><creatorcontrib>T'Sjoen, Guy</creatorcontrib><creatorcontrib>den Heijer, Martin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Physical Education Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of bone and mineral research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wiepjes, Chantal M</au><au>Vlot, Mariska C</au><au>Klaver, Maartje</au><au>Nota, Nienke M</au><au>de Blok, Christel JM</au><au>de Jongh, Renate T</au><au>Lips, Paul</au><au>Heijboer, Annemieke C</au><au>Fisher, Alessandra D</au><au>Schreiner, Thomas</au><au>T'Sjoen, Guy</au><au>den Heijer, Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study</atitle><jtitle>Journal of bone and mineral research</jtitle><addtitle>J Bone Miner Res</addtitle><date>2017-06</date><risdate>2017</risdate><volume>32</volume><issue>6</issue><spage>1252</spage><epage>1260</epage><pages>1252-1260</pages><issn>0884-0431</issn><eissn>1523-4681</eissn><abstract>ABSTRACT Sex steroids are important determinants of bone acquisition and bone homeostasis. Cross‐sex hormonal treatment (CHT) in transgender persons can affect bone mineral density (BMD). The aim of this study was to investigate in a prospective observational multicenter study the first‐year effects of CHT on BMD in transgender persons. A total of 231 transwomen and 199 transmen were included who completed the first year of CHT. Transwomen were treated with cyproterone acetate and oral or transdermal estradiol; transmen received transdermal or intramuscular testosterone. A dual‐energy X‐ray absorptiometry (DXA) was performed to measure lumbar spine (LS), total hip (TH), and femoral neck (FN) BMD before and after 1 year of CHT. In transwomen, an increase in LS (+3.67%, 95% confidence interval [CI] 3.20 to 4.13%, p &lt; 0.001), TH (+0.97%, 95% CI 0.62 to 1.31%, p &lt; 0.001), and FN (+1.86%, 95% CI 1.41 to 2.31%, p &lt; 0.001) BMD was found. In transmen, TH BMD increased after 1 year of CHT (+1.04%, 95% CI 0.64 to 1.44%, p &lt; 0.001). No changes were observed in FN BMD (–0.46%, 95% CI –1.07 to 0.16%, p = 0.144). The increase in LS BMD was larger in transmen aged ≥50 years (+4.32%, 95% CI 2.28 to 6.36%, p = 0.001) compared with transmen aged &lt;50 years (+0.68%, 95% CI 0.19 to 1.17%, p = 0.007). In conclusion, BMD increased in transgender persons after 1 year of CHT. In transmen of postmenopausal age, the LS BMD increased more than in younger transmen, which may lead to the hypothesis that the increase in BMD in transmen is the result of the aromatization of testosterone to estradiol. © 2017 American Society for Bone and Mineral Research.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28370342</pmid><doi>10.1002/jbmr.3102</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0884-0431
ispartof Journal of bone and mineral research, 2017-06, Vol.32 (6), p.1252-1260
issn 0884-0431
1523-4681
language eng
recordid cdi_proquest_miscellaneous_1884168020
source MEDLINE; Access via Wiley Online Library; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals
subjects 17β-Estradiol
Adult
Age
Age Factors
Alcohol Drinking - adverse effects
Body Weight - drug effects
Bone density
Bone Density - drug effects
Bone Density - physiology
Bone mineral density
Bone turnover
Cigarette Smoking - adverse effects
CROSS‐SEX HORMONAL TREATMENT
Cyproterone acetate
Dual energy X-ray absorptiometry
DXA
Estradiol - pharmacology
Female
Femur
Hip
Homeostasis
Humans
Male
Observational studies
Oral cavity
OSTEOPOROSIS
Post-menopause
Prospective Studies
Sex
SEX STEROIDS
Spine (lumbar)
Steroid hormones
Testosterone
Testosterone - pharmacology
Transgender Persons
Vitamin D - pharmacology
Young Adult
title Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T15%3A50%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bone%20Mineral%20Density%20Increases%20in%20Trans%20Persons%20After%201%20Year%20of%20Hormonal%20Treatment:%20A%20Multicenter%20Prospective%20Observational%20Study&rft.jtitle=Journal%20of%20bone%20and%20mineral%20research&rft.au=Wiepjes,%20Chantal%20M&rft.date=2017-06&rft.volume=32&rft.issue=6&rft.spage=1252&rft.epage=1260&rft.pages=1252-1260&rft.issn=0884-0431&rft.eissn=1523-4681&rft_id=info:doi/10.1002/jbmr.3102&rft_dat=%3Cproquest_cross%3E1907558516%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1907558516&rft_id=info:pmid/28370342&rfr_iscdi=true